Low dose synthetic human atrial natriuretic peptide infusion in a patient with mitral stenosis and severe pulmonary hypertension.

Abstract

The present report concerns a case of very low plasma levels of atrial natriuretic peptide (ANP) accompanying severe pulmonary hypertension due to mitral stenosis. There was remarkable fibrosis in the atrium and ANP secretion may have been insufficient. Low-dose infusion (0.025 microg kg(-1) min(-1)) of synthetic human alpha-ANP infusion was very effective in improving the pulmonary hypertension.

• Authors: K Maeda, T Tsutamoto, A Wada, T Hisanaga, T Nishimura, H Yamada, Y Sasaki, M Kinoshita
• Journal: Japanese circulation journal (Jpn Circ J) Vol. 63 Issue 10 Pg. 816-8 (Oct 1999) ISSN: 0047-1828 [Print] Japan
• PMID: 10553928 (Publication Type: Case Reports, Journal Article)

Chemical References

• Atrial Natriuretic Factor

Topics

• Atrial Natriuretic Factor (administration & dosage, blood)
• Heart Failure (drug therapy)
• Humans
• Hypertension, Pulmonary (drug therapy, etiology, therapy)
• Infusions, Intravenous
• Male
• Middle Aged
• Mitral Valve Stenosis (complications, drug therapy, therapy)
• Pulmonary Wedge Pressure
• Time Factors